33.64% -0.0603

Paxmedica Inc (PXMD)

Panoramica Notizia Cronologia dei prezzi Financials Perché PXMD Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

Volume 24 ore:

Relative Volume:

Capitalizzazione di mercato:

Utile/perdita netta:

Rapporto P/E:

Flusso di cassa netto:

1 W Prestazione:

1M Prestazione:

6M Prestazione:

1 anno Prestazione:

Intervallo 1D:

Intervallo di 1 settimana:

Portata 52W:

Paxmedica Inc Stock (PXMD) Company Profile

Paxmedica Inc

Healthcare (1140)

Biotechnology (637)

Prossima data di guadagno

Ultimi documenti SEC

PXMD's Discussions on Twitter

Confronta PXMD con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
PXMD Paxmedica Inc	0.00	0	0	-17.66M	-9.32M	-6.8879
VRTX Vertex Pharmaceuticals Inc	421.39	108.36B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	463.43	60.82B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	577.95	61.02B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	817.32	50.01B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	310.81	34.05B	4.56B	-176.77M	225.30M	-1.7177

Paxmedica Inc Borsa (PXMD) Ultime notizie

Paxmedica Inc Azioni (PXMD) Dati Finanziari

Paxmedica Inc (PXMD)

Paxmedica Inc Stock (PXMD) Company Profile

Confronta PXMD con altri titoli

Paxmedica Inc Borsa (PXMD) Ultime notizie

Contrasting Calliditas Therapeutics AB (publ) (NASDAQ:CALT) & PaxMedica (NASDAQ:PXMD) - Defense World

Delisting of Securities from The Nasdaq Stock Market - The Manila Times

Comparing Intra-Cellular Therapies (NASDAQ:ITCI) and PaxMedica (NASDAQ:PXMD) - Defense World

Kuvatris Therapeutics Renames, Cancels Shares Amid Restructuring - AInvest

PaxMedica Renames to Kuvatris, Cancels Shares - TipRanks

PaxMedica Provides Company Update and Continues to Advance PAX-101 Regulatory Strategy - marketscreener.com

Press Release Distribution & PR Platform - ACCESS Newswire

PaxMedica announces board resignations amid transition - Investing.com

PaxMedica Announces Board Chairman Resignation Amid Transition - TipRanks

PaxMedica Holds Important FDA Type-B Meeting to Review PAX-101 Pivotal Trial Data - ACCESS Newswire

PaxMedica Announces Resignation of Key Executives - TipRanks

PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection - ACCESS Newswire

PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions - ACCESS Newswire

Craft Capital Management Announces Pricing of Initial Public Offering for PaxMedica, Inc. - ACCESS Newswire

PaxMedica Secures Immediate Exercise of Warrants - ACCESS Newswire

PaxMedica, Inc. (PXMD) Stock Price, News, Quote & History - Yahoo

PaxMedica Secures Groundbreaking China Patent for Autism Treatment Breakthrough After 100 Years - Stock Titan

Autism Prevalence Surges Globally, Raising Concerns Among Healthcare Experts - FinancialContent

BioMedNewsBreaks — PaxMedica Inc. (PXMD) Announces Immediate Exercise of Warrants to Total Approximately $884K | Dow Theory Letters - FinancialContent

BioMedNewsBreaks — PaxMedica Inc. (PXMD) Intensifying Efforts to Achieve Significant Program Milestones - FinancialContent

Researchers Say Brain ‘Overgrowth’ Could Contribute to Autism Development - FinancialContent

Silicon Valley - FinancialContent

PaxMedica (NASDAQ: PXMD) Seeking to Qualify for Neglected Tropical Disease Priority Review Voucher - Barchart.com

BioMedNewsBreaks — PaxMedica Inc. (NASDAQ: PXMD) Dedicated to Ensuring Access to Life-Saving Treatments - FinancialContent

PaxMedica Files Nasdaq Delisting Appeal Notice and Prepares for Upcoming FDA Meeting on PAX-101 - Yahoo Finance

PXMD Stock Price and Chart — OTC:PXMD - TradingView

PaxMedica Inc. (NASDAQ: PXMD) Announces PAX-101 Batch Completion for NDA Application to FDA - FinancialContent

PaxMedica's CEO and Malawi Health Official Discuss Urgent Medical Crisis in Bell2Bell Podcast - Yahoo Finance

As Autism Cases Rise, Biopharma Springs Into Action - BioSpace

PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101 - GlobeNewswire

Malawi’s Health Ministry Seeks Emergency Access to PaxMedica’s IV Suramin - NAVLIN DAILY

PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness - Yahoo Finance

Why Is PaxMedica (PXMD) Stock Up 93% Today? - InvestorPlace

PaxMedica Achieves Key Milestone in the Development of - GlobeNewswire

PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments - GlobeNewswire

PaxMedica Accelerates RSU Vesting for Top Executives - TipRanks

PaxMedica (NASDAQ: PXMD) Dedicated to Enhancing Quality of Life for Individuals with ASD - The Globe and Mail

PaxMedica Releases Fireside Chat Video with CEO Howard Weisman - StreetInsider

HC Wainwright & Co. Initiates Coverage of PaxMedica (PXMD) with Buy Recommendation - Nasdaq

PaxMedica (NASDAQ: PXMD) Closes on Public Offering Reaching Estimated $7M - The Globe and Mail

Penny Stocks To Buy? 5 To Watch Right Now - PennyStocks.com

PaxMedica News of FDA Type-B Meeting Shared in Audio Broadcast - Yahoo Finance

PaxMedica (NASDAQ: PXMD) News of FDA Type-B Meeting Shared in Audio Broadcast - The Globe and Mail

PaxMedica Releases Q3 2023 Financial Report, Corporate Update - Yahoo Finance

What LIFW, PXMD, and NVOS have in common - StocksToTrade

Why Is PaxMedica (PXMD) Stock Up 95% Today? - InvestorPlace

PaxMedica Engages Bourne Partners to Explore Future Monetization of Potential Priority Review Voucher (PRV) - FinancialContent

PaxMedica (NASDAQ: PXMD) to jump 1,700% todaypurely nominal and technical - Dhaka Tribune

PaxMedica Announces 1-for-17 Reverse Stock Split - Yahoo Finance

Thinking about buying stock in Nextplay Technologies, ABVC Biopharma, PaxMedica, Mustang Bio, or NXU Inc.? - MarketScreener

Why Is PaxMedica (PXMD) Stock Up Today? - TradingView

Paxmedica Inc Azioni (PXMD) Dati Finanziari

Reddito

Reddito netto

Flusso di cassa

EPS

Simile a PXMD